AAFP: Keep REMS continuing medical education voluntary

08/1/2013 | AAFP News Now

Prescribers should be involved in deciding whether and how risks of certain classes of drugs and biologics will be mitigated in risk evaluation and mitigation strategies, the AAFP's Ann Karty, M.D., told an FDA meeting on the challenges of REMS standardization and assessment. Karty, who presented information on REMS requirements for extended-release and long-acting opioids, said that REMS continuing medical education should remain voluntary for prescribers and that mandating CME could create confusion for physicians and limit patient access to drugs.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD